Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

HMS DIN 00036676

Status: Cancelled Post Market
Holder: ALLERGAN INC
Molecule: MEDRYSONE

Health Canada record

Active ingredient(s)MEDRYSONE 1 %
Dosage formDrops
RouteOphthalmic
SchedulePRESCRIPTION
ClassHuman
ATCS01BA08 MEDRYSONE
Original market date31-Dec-1969
Current status date04-Aug-2011
SourceHealth Canada DPD

Establishment licence of the holder

Allergan Sales, LLC — licence , not currently licensed, last inspection rating C (2025-04-21).

No Canadian shortage report is currently matched to this DIN.

International API supply for MEDRYSONE

0 active FDA Drug Master Files.

Request a quote for HMS

How to read a Canadian DIN record